Company: HCTI
Filing Date: 2025-04-01
Form Type: S-1
Source: 0001213900-25-027277
Chunk: 19

Company: Healthcare Triangle, Inc.
Filing Date: 2025-04-01
Form: S-1
Chunk 19
---
 Company has also entered
into a Registration Rights Agreement (the “Registration Rights Agreement”) dated February 28, 2025 with the selling stockholders
pursuant which we agreed to file the Registration Statement for all of the Registrable Securities within five (5) calendar days of filing
its Annual Report on Form 10-K for fiscal year 2024 and has agreed that the Registration Statement shall be effective no later than 45
days after the filing of such 10-K (if the Securities and Exchange Commission (the “SEC”) has no comments on the Registration
statement and no later than 75 days after the filing of such 10-K if the SEC does have comments. The Company has agreed to pay a daily
penalty to the selling stockholders equal to 0.1% of the subscription amount of the Unit offering for each day it fails to meet the deadlines
described above.

<div align='center'>9

SELLING STOCKHOLDERS</div>

This prospectus relates
to the offer and sale from time to time of up to 1,483,809,885 shares of Common Stock of Healthcare Triangle, Inc. by the selling stockholders.
The number of shares the selling stockholders may sell consists of up to 1,483,809,885 shares of Common Stock, consisting of (i) up to
7,017,429 shares of Common Stock purchased from us by the selling stockholders as part of the Units; (ii) up to 29,173,056 shares of Common
Stock that may be issued to the selling stockholders if they fully exercise the Pre-Funded Warrants; (iii) 361,904,850 shares of Common
Stock that may be issued to the selling stockholders if they fully exercise the Series A Warrants at the floor price of $0.084 per share
and (iv) 1,085,714,550 shares of Common Stock that may be issued to the selling stockholders if they fully exercise the Series B Warrants
using the “alternative cashless exercise” as provided for in the Series B Warrants and prior to such exercise, the exercise
price for all of the shares underlying the Series B Warrants is reset to the floor price of $0.084 per share. The shares of Common Stock
covered by this prospectus will be issued in reliance on exemptions from registration provided by Section 4(a)(2) of the Securities Act
and Rule 506(b) promulgated thereunder